Clyto Online Publishing | Conference | 2nd International Conference on Cancer Care and Cure

2nd International Conference on Cancer Care and Cure

Purpose of Conference

It is to celebrate the discoveries of many researchers, scientists, industrialists and fellow professionals to educate, ideate, network, produce and promote science advancements in curbing and curing the challenges of cancer disease. In that way, here Clyto Access welcomes you to the Conference on Cancer Care and Cure - series II, will be held on 12th-13th February 2018 at Oxford university, UK, with the theme "Innovating science and technology for curbing oncology crisis".

Points to discuss

☛ Non – invasive fluid biopsy implementation
☛ Cancer diagnostics – Real time method PCR etc.
☛ Genetic makeup - Understanding genetic and lifestyle cause of diseases
☛ Preclinical imaging and Bio-imaging
☛ Next generation targeted therapies
☛ Molecular cancer diagnostics – systems approach and others
☛ Artificial intelligence based therapy design – IBM’s Watson, etc.
☛ Multi functional radiology.
☛ In silico trials: organs-on-a-chip technique
☛ DNA Cages
☛ Precision surgery – DaVinci robots, CyberKnife, iKnife etc.
☛ Multidrug resistance in cancer cells

catherine_kirk@clytoaccess.com

Related Topics

Adjuvant therapy, Barium Enema, Benign cancer, Biopsy, Bone marrow transplant, Breast MRI, Cell Signalling, Computed Tomography scan, Colposcopy, Carcinoma, Clinical trials, Chemoprevention, Chemotherapy, Digital rectal exam, Drug development, Fibroid, Gene Therapy, Hormone therapy, Imaging tests, Carcinoma In situ, Invasive cancer, Integrative medicine, Immunotherapy, Leukemia, Localized cancer, Lymphatic system, MUGA scan, Mamography, Malignant cancer, Metastasis, Mastectomy, Neoadjuvant therapy, Oncology, PET-CT Scan, Pap test, Polyp, PSA test, Pre- malignant, Primary cancer, Palliative care, Placebo, Radiation therapy, Sarcoma, Screening, Secondary cancer, Tumor marker tests, Tumor, Targeted treatment, Tumor genetics.
Abstract submission deadline (1st round)
01 July 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
26 May 2017

AGENDA

  • • High unmet medical needs treatment options - Repurposing Drugs in Oncology
  • • Sample multiregional trees and clone trees - Multiregional Tumor Trees Are Not Phylogenies
  • • Immuno oncology lesson – Cancer Nanomedicine
  • • Unexpected Regulators of Cancer Development and Progression - ?d T Cells
  • • Opportunities of Immunotherapy – Neo-antigens, Harnessing T cell response, Pathological mobilization and activities of dendrite cells in tumor-bearing hosts, etc.
  • • Holistic approaches to treat cancer
  • • Oncofertility – a bridge for oncology and reproductive research to explore and expand options for the reproductive future of cancer survivors.
  • • Technology advancements in chemotherapy practices – Chemo ID
  • • Intensity Modulated Radiation Therapy (IMRT) & Image Guided Radiation Therapy (IMGT) with linear accelerator platform, High-Dose Rate Brachytherapy - the new form of radiation therapy.
• Three-dimensional conformal Radiation Therapy - Wide boar CT simulator etc
• Cancer-causing processes at the molecular level
• Biochemical pathways operating in normal and cancer cells and the ways in which they control cell division and cell death , eg: apoptosis etc.
• Regenerative medicine advances in cancer therapies – stem cells a revolution in therapeutics
• Squamous cell carcinoma of the head and neck advancements – a current concern
• Detect cancer earlier by interrogating medical and non-medical data sets using machine and deep-learning • Beating cancer – HPV vaccine
• Developmental therapeutics – Molecular target and drug discovery process
• Patient Centered Outcomes Research
• Discovery and validation of different cancer biomarkers for early diagnosis, prognosis and treatment monitoring
• Embedded, implanted and ingestible sensors and pain management

What is Cancer Care 2018 ?

The new science redefining cancer as a large number of narrowly defined diseases and yielding therapeutic options for an expanding number of patients is rapidly transforming the oncology treatment landscape.


Most health systems are struggling to adapt and embrace this evolution—including the regulatory systems, skilled professionals, diagnostic and treatment infrastructures, and financing mechanisms that are required to serve the needs of cancer patients around the world. These challenges demand urgent attention in light of the strong near-term pipeline of clinically distinctive therapies, and new programs.


The surge of innovation in cancer treatments is catching the attention of health system stakeholders and participants around the world. Providers and patients have more choices – and face more complexity - in treatment options, including the possibility of dramatic increases in progression free and overall survival. Payers are also noticing the impact on drug budgets of longer treatment duration and increased numbers of patients receiving treatment. The focus of the second series of this conference would address these factors.

Who to attend Cancer Care 2018 ?

Dean, Department heads, Professors, Associate Professors, Assistant Professors, PhD Scholars, Graduates, Post Graduates, Junior/Senior Research Fellows and Scientists with a background in oncology related spectrum of study. Anesthesiologist, case manager, dermatologist, registered dietitian, Doctor of osteopathic medicine, dosimetrist, endocrinologist, enterostomal therapist, gastroenterologist , genetic counselor, gynecologic oncologist, hematologist , oncology clinical nurse specialist , medical oncologist , neonatologist, occupational therapist, oncologist, oncology social worker, otolaryngologist , pain specialists, palliative care specialists, pathologist, pediatric oncologist, psychologist, pulmonologist, radiation oncologist, radiation therapist, respiratory therapist, surgical oncologist, thoracic surgeons. Industrial specialists, CEOs, project heads of pharmaceutical companies, clinical trial R&D members, professionals of radiology, imaging, etc equipment industries.

Why to attend Cancer Care 2018 ?

• Every professional who wishes to be a part of the highest level of research and science should share and discuss her/his results and findings in a broad scientific spectrum.
• The best opportunity to do that is to attend scientific conferences, which enables one to get opinions and advice and to gain knowledge.
• Cancer care conference offers opportunities for making connections.
• This conference is a great way to learn about clinical trials, new treatments, and research into which of the old treatments still work best.
• This conference is a platform for industry solution providers and seekers are some of the best people for you to get to know, if you want to learn more about the current business climate.
• Discovering innovative products and services for your business is necessary to stay competitive in today’s fast-paced world.

MARKET ANALYSIS

The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Global Oncology / Cancer diagnostics market is expected to garner $13.1 billion by 2020, from an estimate of $7.1 billion in 2015, registering a CAGR of 12.9% during the forecast period 2014 to 2020. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Immunotherapy, Artificial intelligence, Molecular cancer diagnostics, etc are emerging as potential therapies to find the permanent cure for various cancer types. Global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.

CONFERENCE HIGHLIGHTS

"Latest Development and Novel Treatment for Cancer" will explore the fields of  Cancer Immunology & Vaccines, Cancer Screening & Diagnosis, Innovations in prevention and screening, Biomarkers, Leukemia, health professional cancers, Organ Specific Cancers, Childhood cancer, Anti-Cancer Drug Discovery & Therapy, Industrial cancer, Non-Hodgkin Lymphoma, Head and Neck Cancer, Gilomas, Kidney Cancer, Soft Tissue Sarcoma, AIDS-Related Cancer and etc..
prominent speakers from the industry with prodigious experiences.
leading professionals of the industry with valuable skills.
Emerging researchers in the respective field.
You will have a great opportunity to share your research concerns or challenges with the leading experts in the field.
You have an opportunity to raise your doubts and getting answers from the experts.
Programs Programs Detail Time
1

SPOT REGISTRATIONS

08:00 AM
2

INAUGURATION OF CANCER CARE - 2017

09:00 AM
3

KEYNOTE SESSIONS #1

09:30 AM
4

REFRESHMENTS BREAK


10:30 AM
5

KEYNOTE SESSIONS #2


11:00 AM
6

REFRESHMENTS - LUNCH BREAK


12:30 PM
7

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE


01:30 PM
8

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE


03:30 PM
9

EDITORIAL BOARD MEETING - JOURNAL OF ONCOLOGICAL STUDIES

DISCUSSING ON GROWTH AND DEVELOPMENT OF CLYTO ACCESS' JOURNAL OF ONCOLOGICAL STUDIES



05:00 PM
10

DAY #1 - CLOSURE


06:00 PM

venue

UK

address